GLP-1 receptor agonist toxicity

Background

  • GLP-1 receptor agonists (e.g., semaglutide) are injectable medication used for diabetes management and weight loss
  • Poison control centers have reported increasing inquiries related to possible overdoses

Clinical Features

Differential Diagnosis

Evaluation

Workup

Diagnosis

Management

Disposition

See Also

External Links

References

Obtenido de «https://www.wikem.org/w/index.php?title=GLP-1_receptor_agonist_toxicity&oldid=372348»